Browse Related Topics For:

Hatch-Waxman

217
Pharmaceutical Industry
214
Patents
208
Generic Drugs
198
Pharmaceutical Patents
183
Patent Infringement
169
Patent Litigation
149
ANDA
145
Prescription Drugs
112
FDA
76
Patent-in-Suit
44
Intellectual Property Protection
38
SCOTUS
33
FTC
33
Reverse Payment Settlement Agreements
32
FTC v Actavis
28
Mylan Pharmaceuticals
25
Teva Pharmaceuticals
20
Actavis Inc.
19
Pay-For-Delay
19
Personal Jurisdiction
18
BPCIA
18
Popular
17
Biosimilars
16
Inter Partes Review (IPR) Proceeding
15
Antitrust Litigation
15
Watson Pharmaceuticals
14
Sandoz
13
America Invents Act
13
Appeals
12
AstraZeneca
12
Patent Trial and Appeal Board
10
Anti-Competitive
10
Apotex
10
Settlement
9
Merck
9
Prior Art
9
Safe Harbors
8
Biologics
8
Claim Construction
8
Eli Lilly
8
Endo Pharmaceuticals
8
Patent Applications
8
Rule-of-Reason Analysis
8
Sherman Act
7
Cephalon
7
DaimlerChrysler v Bauman
7
Declaratory Judgments
7
GlaxoSmithKline
7
Novartis
7
Obviousness
7
Otsuka Pharmaceutical
7
Sandoz v Amgen
7
USPTO
6
Allergan Inc
6
Amgen
6
Bayer
6
Corporate Counsel
6
FDA Approval
6
FDCA
6
Hospira
6
Infringement
6
Motion to Dismiss
6
Orange Book
6
Patent Invalidity
6
Preliminary Injunctions
6
Summary Judgment
6
Warner Chilcott
5
Antitrust Violations
5
Class Action
5
Classen Immunotherapies
5
Commercial Marketing
5
Induced Infringement
5
No-AG Agreement
5
On-Sale Bar
5
Patent Reform
5
Patent-Eligible Subject Matter
5
Preemption
5
Roxane Laboratories
5
Takeda Pharmaceuticals
5
Teva v Sandoz
4
Discovery
4
Elan Pharmaceuticals
4
Federal Rule 12(b)(6)
4
Jurisdiction
4
Labeling
4
Manufacturers
4
Minimum Contacts
4
Patent Dance
4
Pleading Standards
4
Product Hopping
4
Shire Development v Watson
4
Specific Jurisdiction
4
Standard of Review
4
Standing
4
Subject Matter Jurisdiction
3
aBLA
3
Allergan v Sandoz
3
Antitrust Provisions
3
Article III
3
Aurobindo Pharmaceuticals
3
Biologics Price Competition and Innovation Act of 2009
3
Biotechnology
3
De Novo Standard of Review
3
Disgorgement
3
Dismissals
3
Exclusivity
3
Failure To Warn
3
Healthcare
3
Hedge Funds
3
Innovation Act
3
Noninfringement
3
Notice Requirements
3
Par Pharmaceutical
3
Patent Trolls
3
Product Exclusivity
3
Putative Class Actions
3
Reverse Payments
3
Spectrum
3
Unfair Competition
2
Amarin
2
Brand
2
Burden of Proof
2
CA Supreme Court
2
Canada
2
Cartwright Act
2
Certiorari
2
Competition
2
DaimlerAG
2
Damages
2
Disclosure Requirements
2
Doctrine of Equivalents
2
Estoppel
2
EU
2
Forest Laboratories
2
Forum Selection
2
Forum Shopping
2
Fresenius
2
Generic
2
Genzyme
2
Injunctions
2
Innovation
2
Intellectual Property Litigation
2
Licensing Rules
2
Life Sciences
2
Mayo v. Prometheus
2
Medicare Modernization Act
2
Method Claims
2
Monopolization
2
Motion To Stay
2
Mutual Pharmaceuticals v Bartlett
2
Nexium
2
Non-Practicing Entities
2
Orphan Drugs
2
OxyContin
2
Pfizer
2
PLIVA v Mensing
2
Presumption of Validity
2
Proposed Regulation
2
Sanofi
2
SmithKline Beecham
2
SNDAs
2
TC Heartland LLC v Kraft Foods
2
Trade Agreements
2
Validity
2
Written Descriptions
1
Abbott Laboratories
1
AbbVie
1
Abuse of Process
1
Affordable Care Act
1
Amicus Briefs
1
AMP v Myriad
1
Annual Reports
1
Antibiotics
1
Antitrust Conspiracies
1
Antitrust Division
1
Antitrust Injuries
1
Antitrust Standing
1
Attorney Disbarrment
1
Attorney-Client Privilege
1
Australia
1
Automatic Stay
1
Balancing Test
1
Bifurcation
1
Biofuel
1
Biogen Idec
1
Biopharmaceutical
1
Bipolar Disorder
1
Boehringer
1
Bowman v Monsanto
1
Broadest Reasonable Interpretation Standard
1
Burden-Shifting
1
But For Causation
1
CAFA
1
Cancer
1
Causation
1
Chevron Deference
1
China
1
China FDA
1
Cipro
1
Cisco v CommilUSA
1
Claim Preclusion
1
Class Certification
1
Clear and Convincing Evidence
1
Clear Error Standard
1
Clinical Trials
1
CLS Bank v Alice Corp
1
Coca Cola
1
Collateralized Debt Obligations
1
Combination Products
1
Comment Period
1
Compliance
1
Congressional Committees
1
Consent Order
1
Consideration
1
Contraceptives
1
Controlled Substances Act
1
Counterclaims
1
Covered Business Method Patents
1
Covered Business Method Proceedings
1
Cuozzo Speed Technologies
1
Dart Cherokee Basin Operating Co. v. Owens
1
Data Protection
1
DEA
1
Death Penalty
1
Dell
1
Denial of Certiorari
1
Design Defects
1
Design Patent
1
Direct Purchasers
1
Dirks v SEC
1
Discovery Schedule
1
DNA
1
Drug Approvals
1
Drug Compounding
1
Drug Pricing
1
Drug Safety
1
Duty to Deal
1
Duty to Update
1
eBay
1
Emerging Markets
1
Employer Mandates
1
Enforcement
1
Enforcement Actions
1
Enforcement Statistics
1
EPA
1
European Patent Office
1
Ex Partes Reexamination
1
Exemptions
1
Expert Testimony
1
Exports
1
Extrinsic Evidence
1
Fair Market Value
1
False Advertising
1
Federal Jurisdiction
1
Federal Rule 12(b)(1)
1
Federal Rules of Civil Procedure
1
Financial Crisis
1
Foreign Corporations
1
Foreign Defendants
1
Forum
1
Forum Non Conveniens
1
Fraud
1
General Jurisdiction
1
Goodyear
1
Hague Convention
1
Healthcare Costs
1
Hindsight Reconstruction
1
Human Genes
1
India
1
Injury-in-Fact
1
Innovator Liability
1
Insider Trading
1
Integra
1
Inter Partes Reexamination
1
InterDigital Communications v ITC
1
Internal Investigations
1
Inventions
1
ITC
1
Jazz Pharmaceuticals
1
Joinder
1
Jury Verdicts
1
Justiciable Controversy
1
KBR (formerly Kellogg Brown & Root)
1
Laches
1
Lanham Act
1
Leave to Amend
1
License Agreements
1
Loss Causation
1
Manufacturing Defects
1
Market Manipulation
1
Marketing
1
Markman Hearing
1
Material Misrepresentation
1
Medical Devices
1
Medical Research
1
Misrepresentation
1
Monsanto
1
Morgan Stanley
1
Motion for Reconsideration
1
Motion to Amend
1
Myriad
1
New Trial
1
Nintendo
1
Non-Appealable Decisions
1
Off-Label Use
1
Omissions
1
Omnicare v Laborers District Council
1
Opioid
1
Oral Argument
1
Out-of-State Companies
1
Patent Agent Privilege
1
Patent Assertion Entities
1
Patent Exhaustion
1
Patent Term Adjustment
1
Patent Term Extensions
1
Patent-Misuse
1
Patentability Search
1
Pending Legislation
1
Permanent Injunctions
1
Personal Benefit
1
Petition For Rehearing
1
PHRMA
1
Pleadings
1
POM Wonderful
1
Post-Grant Review
1
Presidential Elections
1
Price Manipulation
1
Prilosec
1
Prioritized Examination
1
Privilege Waivers
1
Proctor & Gamble
1
Product Defects
1
Product Labels
1
Product of Nature Doctrine
1
Professional Conferences
1
Prometheus
1
Proposed Amendments
1
Quality Control Plan
1
RanBaxy
1
Registration Requirement
1
Regulatory Agenda
1
Regulatory Standards
1
Reissue Patents
1
Removal
1
Research and Development
1
Restraining Orders
1
Reversal
1
RICO
1
Ripeness
1
ROI
1
Royalties
1
Rule 26
1
Rulemaking Process
1
Sales Contracts
1
Scienter
1
Scope of Discovery Requests
1
Section 337
1
Settlement Agreements
1
Sham Litigation Exception
1
Single Occurrence
1
Standard of Proof
1
State Law Tort Claims
1
State of Incorporation
1
STRONG Patents Act
1
Supplemental Examination
1
Supply Chain
1
Tolling
1
Trademark Infringement
1
TRIPS Agreement
1
TRO
1
Tyco
1
Uniform Commercial Code (UCC)
1
USDA
1
Vacated
1
Vaccinations
1
Valuation
1
Venue
1
Veterinarians
1
Veterinary Products
1
Warning Labels
1
White Collar Crimes
1
WIPO
1
Work Product Privilege
1
World Intellectual Property Organisation